Skip to main content Accessibility help
×
Home

Smokers’ Treatment Expectancies Predict Smoking Cessation Success

  • Lisa M. Fucito (a1), Benjamin A. Toll (a1) (a2) (a3), Corey R. Roos (a1) (a4) and Andrea C. King (a5)

Abstract

Introduction: Smokers’ treatment expectancies may influence their choice of a particular medication as well as their medication experience.

Aims: This study examined the role of smokers’ treatment expectancies to their smoking cessation outcomes in a completed, randomized, placebo-controlled trial of naltrexone for smoking cessation, controlling for perceptions of treatment assignment.

Methods: Treatment-seeking cigarette smokers (N = 315) were randomized to receive either naltrexone (50 mg) or placebo in combination with nicotine patch and behavioural counselling. Expectancies for naltrexone as a smoking cessation aid were assessed at baseline and four weeks after the quit date.

Results: More positive baseline medication expectancies predicted higher quit rates at one month in the naltrexone group (OR = 1.45, p = 0.04) but were associated with lower quit rates in the placebo group (OR = 0.66, p = 0.03). Maintaining and/or increasing positive medication expectancies in the first month of treatment was associated with better pill adherence during this interval in the naltrexone group (ps < 0.05). Positive baseline medication expectancies were also associated with the perception of having received naltrexone over placebo among all participants.

Conclusions: Positive medication expectancies in smokers may contribute to better treatment response. Assessing treatment expectancies and attempting to maintain or improve them may be important for the delivery, evaluation, and targeting of smoking cessation treatments.

Copyright

Corresponding author

Address for correspondence: Lisa M. Fucito, Department of Psychiatry, Yale University School of Medicine, 1 Long Wharf Drive, Box 18, New Haven, CT 06511, USA. Email: lisa.fucito@yale.edu

References

Hide All
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50 (2), 179.
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84 (2), 191215.
Bansal, M., Cummings, K. M., Hyland, A., & Giovino, G. (2004). Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? Nicotine & Tobacco Research, 6 (6), 303310.
Centers for Disease Control. (2013). Prevalence of current smoking among adults aged 18 and over: United States, 1997–2012. Retrieved July 30, 2013. http://www.cdc.gov/tobacco/data_statistics/mmwrs/byyear/2014/mm6302a2/intro.htm
Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001). Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 3 (1), 716. doi: 10.1080/14622200020032051
Cummings, K. M., Hyland, A., Giovino, G., Hastrup, J., Bauer, J., & Bansal, M. (2004). Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine & Tobacco Research, 6 (6), 333340.
Etter, J. F., & Perneger, T. V. (2001). Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clinical Pharmacology & Therapeutics, 69 (3), 175183.
Ferguson, S. G., Gitchell, J. G., Shiffman, S., Sembower, M. A., Rohay, J. M., & Allen, J. (2011). Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt. Addictive Behaviors, 36 (7), 713716.
Finniss, D. G., & Benedetti, F. (2005). Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain, 114 (1–2), 36.
Fiore, M., Jaén, C., Baker, T., Bailey, W. C., Benowitz, N. L., Curry, S. J., et al. (2008). Treating tobacco use and dependence: 2008 update. Public Health Service sponsored Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services.
Fucito, L. M., & Juliano, L. M. (2007). Effects of instructions on responses to the nicotine patch: A laboratory study. Psychopharmacology (Berl), 194 (4), 475483.
Fucito, L. M., Toll, B. A., Salovey, P., & O’Malley, S. S. (2009). Beliefs and attitudes about bupropion: Implications for medication adherence and smoking cessation treatment. Psychology of Addictive Behaviors, 23 (2), 373379.
Hammond, D., McDonald, P. W., Fong, G. T., & Borland, R. (2004). Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction, 99 (8), 10421048.
Holmbeck, G. N. (2002). Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations. Journal of Pediatric Psychology, 27 (1), 8796.
Hutchison, K. E., Monti, P. M., Rohsenow, D. J., Swift, R. M., Colby, S. M., Gnys, M. et al. (1999). Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology (Berl), 142 (2), 139143.
Juliano, L. M., & Brandon, T. H. (2004). Smokers’ expectancies for nicotine replacement therapy vs. cigarettes. Nicotine & Tobacco Research, 6 (3), 569574.
King, A. C., Cao, D., O’Malley, S. S., Kranzler, H. R., Cai, X., deWit, H. et al. (2012). Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. Journal of Clinical Psychopharmacology, 32 (5), 630636.
King, A. C., Cao, D., Vanier, C., & Wilcox, T. (2009). Naltrexone decreases heavy drinking rates in smoking cessation treatment: An exploratory study. Alcoholism: Clinical & Experimental Research, 33 (6), 10441050.
King, A. C., de Wit, H., Riley, R. C., Cao, D., Niaura, R., & Hatsukami, D. (2006). Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences. Nicotine & Tobacco Research, 8 (5), 671682.
King, A. C., Sánchez-Johnsen, L., Van Orman, S., Cao, D., & Matthews, A. K. 2008. A pilot community-based intensive smoking cessation intervention in African Americans: Feasibility, acceptability, and early outcome indicators. Journal of the National Medical Association, 100, 208217.
Kirsch, I. (1985). Response expectancy as a determinant of experience and behavior. American Psychologist, 40 (11), 11891202.
Kirsch, I. (1997). Specifying nonspecifics: Psychological mechanisms of placebo effects. In: A. Harrington (Ed.) The placebo effect: Interdisciplinary explorations (pp. 166–186). Cambridge, MA: Harvard University Press.
Krishnan-Sarin, S., Meandzija, B., & O’Malley, S. (2003). Naltrexone and nicotine patch in smoking cessation: A preliminary study. Nicotine & Tobacco Research, 5 (6), 851857.
Mooney, M. E., Leventhal, A. M., & Hatsukami, D. K. (2006). Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine & Tobacco Research, 8 (3), 435446.
Ockene, J. K., Emmons, K. M., Mermelstein, R. J., Perkins, K. A., Bonollo, D. S., Voorhees, C. C. et al. (2000). Relapse and maintenance issues for smoking cessation. Health Psychology, 19, 1731.
O’Malley, S. S., Cooney, J. L., Krishnan-Sarin, S., Dubin, J. A., McKee, S. A., Cooney, N. L. et al. (2006). A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Archives of Internal Medicine, 166 (6), 667674.
O’Malley, S. S., Krishnan-Sarin, S., McKee, S. A., Leeman, R. F., Cooney, N. L., Meandzija, B. et al. (2009). Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. International Journal of Neuropsychopharmacology, 12 (5), 589597.
Robinson, J. D., Lam, C. Y., Carter, B. L., Wetter, D. W., & Cinciripini, P. M. (2012). Negative reinforcement smoking outcome expectancies are associated with affective response to acute nicotine administration and abstinence. Drug & Alcohol Dependendence, 120 (1–3), 196201.
Schnoll, R. A., Epstein, L., Audrain, J., Niaura, R., Hawk, L., Shields, P. G. et al. (2008). Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. Journal of Substance Abuse Treatment, 34 (2), 234241.
Shiffman, S., Ferguson, S. G., Rohay, J., & Gitchell, J. G. (2008). Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: Relationship with use and compliance. Addiction, 103 (8), 13711378.
Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back: A technique for assessing self-reported alcohol consumption. In Litten, R. Z. & Allen, J. P. (Eds.), Measuring alcohol consumption: Psychosocial and biochemical methods (pp. 4172). Totowa, NJ: Humana Press.
Tate, J. C., Stanton, A. L., Green, S. B., Schmitz, J. M., Le, T., & Marshall, B. (1994). Experimental analysis of the role of expectancy in nicotine withdrawal. Psychology of Addictive Behaviors, 8 (3), 169178.
Thomas, J. L., Guo, H., Lynam, I. M., Powell, J. N., Okuyemi, K. S., Bronars, C. A. et al. (2008). The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers. Journal of General Internal Medicine, 23 (9), 13611366.
Vogt, F., Hall, S., & Marteau, T. M. (2008). Understanding why smokers do not want to use nicotine dependence medications to stop smoking: Qualitative and quantitative studies. Nicotine & Tobacco Research, 10 (8), 14051413.
Vogt, F., Hall, S., & Marteau, T. M. (2010). Examining why smokers do not want behavioral support with stopping smoking. Patient Education & Counseling, 79 (2), 160166.
Vogt, F., & Marteau, T. M. (2012). Perceived effectiveness of stop smoking interventions: Impact of presenting evidence using numbers, visual displays, and different timeframes. Nicotine & Tobacco Research, 14 (2), 200208.
Walsh, Z., Epstein, A., Munisamy, G., & King, A. (2008). The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation. Journal of Addictive Diseases, 27 (1), 6572.
Zbikowski, S. M., Jack, L. M., McClure, J. B., Deprey, M., Javitz, H. S., McAfee, T. A. et al. (2011). Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine & Tobacco Research, 13 (5), 319327.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed